SBFM
SBFM
NASDAQ · Biotechnology

Sunshine Biopharma Inc

$2.11
-0.07 (-3.21%)
Financial Highlights (FY 2026)
Revenue
182.07M
Net Income
-29,966,016
Gross Margin
33.8%
Profit Margin
-16.5%
Rev Growth
+102.9%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 33.8% 61.7% 61.7% 61.7%
Operating Margin -17.1% 14.3% 13.3% 12.7%
Profit Margin -16.5% 9.5% 9.5% 12.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 182.07M 953.7K 857.2K 883.5K
Gross Profit 61.47M 588.6K 529.1K 545.3K
Operating Income -31,225,426 136.7K 113.8K 112.4K
Net Income -29,966,016 90.7K 81.5K 110.3K
Gross Margin 33.8% 61.7% 61.7% 61.7%
Operating Margin -17.1% 14.3% 13.3% 12.7%
Profit Margin -16.5% 9.5% 9.5% 12.5%
Rev Growth +102.9% +23.3% +22.6% +12.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 3.14M 2.46M 3.00M
Total Equity 4.51M 5.12M 4.93M
D/E Ratio 0.69 0.48 0.61
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -29,563,031 169.7K 158.3K 158.7K
Free Cash Flow 104.6K 58.4K 79.5K